Medicon Hellas S.A. (ATH:MEDIC)
Greece · Delayed Price · Currency is EUR 2.890
+0.040 (1.40%)
Last updated: Jun 12, 2026, 11:07 AM EET
Medicon Hellas Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 17.95 | 18.12 | 18.12 | 20.77 | 21.51 | |
Revenue Growth (YoY) | -0.94% | 0.03% | -12.77% | -3.41% | 40.87% |
Cost of Revenue | 4.84 | 5.24 | 5.1 | 5.29 | 5.82 |
Gross Profit | 13.11 | 12.88 | 13.02 | 15.48 | 15.69 |
Selling, General & Admin | 9.89 | 10.29 | 10.45 | 10.99 | 10.13 |
Research & Development | 1.04 | 0.93 | 0.92 | 0.77 | 0.91 |
Other Operating Expenses | -0.02 | 0.01 | -0.14 | -0.12 | -0.34 |
Operating Expenses | 10.91 | 11.23 | 11.24 | 11.63 | 10.7 |
Operating Income | 2.21 | 1.65 | 1.78 | 3.85 | 4.99 |
Interest Expense | -0.4 | -0.58 | -0.58 | -0.26 | -0.27 |
Interest & Investment Income | 0.27 | 0.41 | 0.58 | 0.15 | 0.13 |
Currency Exchange Gain (Loss) | -0 | 0 | -0 | -0.01 | -0.02 |
Other Non Operating Income (Expenses) | -0.06 | -0.17 | -0.31 | -0.07 | -0.08 |
EBT Excluding Unusual Items | 2.02 | 1.31 | 1.47 | 3.66 | 4.74 |
Gain (Loss) on Sale of Investments | - | 0.12 | -0 | 0 | - |
Gain (Loss) on Sale of Assets | 0.05 | -0.01 | 0.02 | -0 | 0.03 |
Pretax Income | 2.07 | 1.42 | 1.5 | 3.66 | 4.78 |
Income Tax Expense | 0.3 | 0.19 | 0.27 | 0.96 | 1.54 |
Earnings From Continuing Operations | 1.77 | 1.23 | 1.23 | 2.7 | 3.24 |
Earnings From Discontinued Operations | - | 0.05 | 0.11 | - | - |
Net Income to Company | 1.77 | 1.28 | 1.34 | 2.7 | 3.24 |
Minority Interest in Earnings | -0.04 | 0.08 | -0.01 | -0.17 | -0.2 |
Net Income | 1.73 | 1.37 | 1.32 | 2.53 | 3.04 |
Net Income to Common | 1.73 | 1.37 | 1.32 | 2.53 | 3.04 |
Net Income Growth | 26.81% | 3.38% | -47.83% | -16.68% | 301.85% |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 |
EPS (Basic) | 0.39 | 0.31 | 0.30 | 0.57 | 0.69 |
EPS (Diluted) | 0.39 | 0.31 | 0.30 | 0.57 | 0.69 |
EPS Growth | 26.81% | 3.38% | -47.83% | -16.68% | 301.85% |
Free Cash Flow | 2.91 | 1 | -0.72 | 0.84 | 4.24 |
Free Cash Flow Per Share | 0.66 | 0.23 | -0.16 | 0.19 | 0.96 |
Dividend Per Share | - | 0.130 | 0.060 | 0.153 | - |
Dividend Growth | - | 116.67% | -60.82% | - | - |
Gross Margin | 73.04% | 71.07% | 71.86% | 74.52% | 72.94% |
Operating Margin | 12.30% | 9.10% | 9.84% | 18.52% | 23.18% |
Profit Margin | 9.65% | 7.54% | 7.29% | 12.20% | 14.14% |
Free Cash Flow Margin | 16.21% | 5.49% | -3.95% | 4.05% | 19.70% |
EBITDA | 3.39 | 2.93 | 3.08 | 5.09 | 6.13 |
EBITDA Margin | 18.91% | 16.16% | 17.02% | 24.52% | 28.51% |
D&A For EBITDA | 1.19 | 1.28 | 1.3 | 1.25 | 1.14 |
EBIT | 2.21 | 1.65 | 1.78 | 3.85 | 4.99 |
EBIT Margin | 12.30% | 9.10% | 9.84% | 18.52% | 23.18% |
Effective Tax Rate | 14.62% | 13.08% | 18.23% | 26.14% | 32.15% |